Meissa Vaccines Revenue and Competitors
Estimated Revenue & Valuation
- Meissa Vaccines's estimated annual revenue is currently $2.3M per year.
- Meissa Vaccines's estimated revenue per employee is $155,000
Employee Data
- Meissa Vaccines has 15 Employees.
- Meissa Vaccines grew their employee count by -29% last year.
Meissa Vaccines's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | SVP | Reveal Email/Phone |
4 | VP Clinical Development | Reveal Email/Phone |
5 | Senior Director, Head Quality | Reveal Email/Phone |
6 | Sr. Director Clinical Operations | Reveal Email/Phone |
7 | Associate Director Virology | Reveal Email/Phone |
8 | Chief Manufacturing Officer | Reveal Email/Phone |
9 | Senior Director Clinical Development | Reveal Email/Phone |
10 | Senior Director CMC | Reveal Email/Phone |
Meissa Vaccines Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Meissa Vaccines?
Meissa is a private biotech company focused on the advancement of vaccines for respiratory viruses. Meissa was founded on proprietary technologies employing reverse genetics for rational design of more effective live attenuated vaccines. The technology is exclusively licensed from Emory University and Children's Healthcare of Atlanta. Dr. Moore, together with Dr. Roderick Tang, a vaccine biotech expert, co-founded Meissa. They are supported by a team with extensive experience in all aspects of vaccine development. Meissa is currently a resident company at the Johnson & Johnson Innovation – JLABS in South San Francisco.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Meissa Vaccines News
Researchers at Meissa Vaccines in California use a version of the respiratory syncytial virus that has been weakened and covered with...
The next leap in coronavirus vaccine development could be a nasal ... Researchers at Meissa Vaccines in California use a version of the...
Another example: one of the intranasal vaccines developed by NIH groups ... MV-014-212, Meissa Vaccines (USA), Viral vector (RSV), Phase 1
Other Companies in Downtown Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.1M | 97 | -18% | N/A |